Welcome to LookChem.com Sign In | Join Free

Science Details

Home > Chemical Encyclopedia > Science List > Details
  • Baicalin (cas 100647-26-5) regulates SirT1/STAT3 pathway and restrains excessive hepatic glucose production

  • Add time:08/11/2019    Source:sciencedirect.com

    Sirtuin 1 (SirT1) and signal transducer and activator of transcription 3 (STAT3) oppositely regulate hepatic gluconeogenic genes and the association remains to be elucidated. Baicalin (cas 100647-26-5) is a natural flavonoid with beneficial effects on glucose and lipid metabolism. This study aims to investigate the effect of baicalin on hepatic gluconeogenesis with focus on the regulation of fatty acid mobilization and SirT1/STAT3 pathway. In HFD feeding or fasting state, hepatic gluconeogenesis and fatty acid oxidation induced SirT1 expression due to the increased nicotinamide adenine dinucleotide+ (NAD+) contents. Baicalin reduces endogenous glucose production via suppression of hepatic gluconeogenesis and decreased SirT1 induction via reducing NAD+ accumulation in an energy-sensing way. Fasting increased SirT1 protein in STAT3 immunoprecipitation products and less in the liver of baicalin-treated mice, indicating that baicalin blocked the binding of SirT1 to STAT3 and thus preserved STAT3 acetylation. SirT1 knockdown enhanced the protective effect of baicalin on pyruvate-induced STAT3 phosphorylation and acetylation, these results further indicated that the regulation of STAT3 activity by baicalin was dependent on SirT1. Moreover, HFD feeding increased gene expression for PGC-1α in the liver, but the transcriptional regulation was inhibited by baicalin treatment. SirT1 overexpression and STAT3 inhibition enhanced pyruvate-mediated PGC-1α gene expression, suggesting that deacetylation of STAT3 by SirT1 is required for PGC-1α activity on hepatic gluconeogenesis. Taken together, these results showed that baicalin restrained HGP via inhibiting SirT1 activity coupled with STAT3 acetylation and subsequent PGC-1α suppression, suggesting that hepatic SirT1 and STAT3 pathway may provide therapeutic advantages for the control of hyperglycemia.

    We also recommend Trading Suppliers and Manufacturers of Baicalin (cas 100647-26-5). Pls Click Website Link as below: cas 100647-26-5 suppliers

    Prev:Baicalin (cas 100647-26-5) protects mouse testis from injury induced by heat stress
    Next:Inhibition mechanism of baicalein and Baicalin (cas 100647-26-5) on xanthine oxidase and their synergistic effect with allopurinol)

  • Back】【Close 】【Print】【Add to favorite
Periodic Table
    Related Products